Home/Filings/4/0001562180-23-007980
4//SEC Filing

JONAS JEFFREY M 4

Accession 0001562180-23-007980

CIK 0001597553other

Filed

Nov 29, 7:00 PM ET

Accepted

Nov 30, 4:04 PM ET

Size

8.6 KB

Accession

0001562180-23-007980

Insider Transaction Report

Form 4
Period: 2023-11-28
JONAS JEFFREY M
DirectorSee Remarks
Transactions
  • Tax Payment

    Common Stock

    2023-11-28$19.27/sh3,935$75,827128,046 total
  • Award

    Common Stock

    2023-11-28+10,000131,981 total
Footnotes (1)
  • [F1]On March 25, 2020, the reporting person was granted Performance Stock Units (PSUs) to acquire a total of 25,000 shares of common stock. The PSUs vest upon the achievement of certain milestones, one of which was met on November 28, 2023, resulting in the vesting of the PSUs as to 10,000 shares.

Issuer

Sage Therapeutics, Inc.

CIK 0001597553

Entity typeother

Related Parties

1
  • filerCIK 0001042021

Filing Metadata

Form type
4
Filed
Nov 29, 7:00 PM ET
Accepted
Nov 30, 4:04 PM ET
Size
8.6 KB